Psychedelic drug MDMA eases PTSD symptoms in a study that paves the way for possible US approval
PTI, Sep 15, 2023, 9:51 AM IST
Credit: iStock Photo
The psychedelic drug MDMA can reduce symptoms of post-traumatic stress disorder, researchers reported in a new study published on Thursday.
The company sponsoring the research said it plans later this year to seek US approval to market the drug, also known as ecstasy, as a PTSD treatment when combined with talk therapy.
“It’s the first innovation in PTSD treatment in more than two decades. And it’s significant because I think it will also open up other innovation,” said Amy Emerson, CEO of MAPS Public Benefit Corporation, the research sponsor.
Earlier this year, Australia became the first country to allow psychiatrists to prescribe MDMA and psilocybin, the psychoactive ingredient in psychedelic mushrooms. The drugs are gaining wider cultural acceptance in the US in part because of efforts by the nonprofit advocacy group Multidisciplinary Association for Psychedelic Studies.
For the new study, researchers measured symptoms in 104 people with PTSD who were randomly assigned to get either MDMA or a dummy pill during three sessions, one month apart. Both groups received talk therapy.
Common side effects in the MDMA group were muscle tightness, nausea, decreased appetite and sweating. But only one person in the MDMA group dropped out of the study.
After treatment, 86 per cent of the MDMA group improved on a standard PTSD assessment compared to 69 per cent of the placebo group. The assessment measures symptoms such as nightmares, flashbacks and insomnia.
By the study’s end, 72 per cent of people in the MDMA group no longer met the diagnostic criteria for PTSD, compared to about 48 per cent of the placebo group.
“The results that they got are very exciting,” said Barbara Rothbaum, who directs the Emory Healthcare Veterans Program in Atlanta. She was not involved in the research, which was published in the journal Nature Medicine.
PTSD also can be treated with other medications or talk therapy.
“They are very effective, but nothing is 100 per cent effective,” Rothbaum said. “So we absolutely need more options for treatment.” Before MDMA could be prescribed in the US, the Food and Drug Administration would need to approve it and the Drug Enforcement Administration would need to change its classification. MDMA is currently classified as Schedule 1, on par with heroin and deemed to have “no currently accepted medical use and a high potential for abuse”.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Poor sleep in early middle age related with accelerated brain ageing, study finds
Majority in survey support smoke-free public places in India
Liver disease is often associated with obesity and diabetes. How can it be detected, and can it be treated? Expert advice.
Schizophrenia linked with four times higher risk of death from sudden heart attack
Over 77% of India’s children lack WHO-suggested diversity in diet, study finds
MUST WATCH
Latest Additions
Varanasi court rejects Hindu side’s plea for survey through excavation in Gyanvapi complex
‘Do they get free power in UP, Haryana?’ Kejriwal asks people at rally
Nomination process ends for bypolls to 47 assembly seats in 13 states
Hard-working poor people robbed of dreams due to falling incomes, rising inflation: Rahul
Police book 7 ‘fake’ ED officers who ‘raided’ Delhi man, sought Rs 5 crore
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.